BioCentury
ARTICLE | Financial News

Rexahn planning $20 million direct offering

January 16, 2014 12:47 AM UTC

Rexahn Pharmaceuticals Inc. (NYSE-M:RNN) plans to raise about $20 million through the sale of about 19.1 million units at $1.05 in a registered direct offering. Each unit comprises a share and a five-...